The D5 dopamine receptor mediates large-conductance, calcium- and voltage-activated potassium channel activation in human coronary artery smooth muscle cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 2, 2010, Pages 640-649

  Natarajan, Aruna ^a   Han, Guichun ^c   Chen, Shi You ^d   Yu, Peiying ^e,f   White, Richard ^b   Jose, Pedro ^e,f  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; FENOLDOPAM; KT 5720; KT 5823; POTASSIUM CHANNEL; CARBAZOLE DERIVATIVE; ENZYME INHIBITOR; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PYRROLE DERIVATIVE;

ARTICLE; CONDUCTANCE; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; ELECTRIC POTENTIAL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; PHYSIOLOGY;

CARBAZOLES; CELLS, CULTURED; CORONARY VESSELS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDES, ANTISENSE; PYRROLES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5;

EID: 76749172150     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.159871     Document Type: Article

References (40)

1. Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, and Ricci A (2000) Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 22:277-288.
2. Amenta F, Ricci A, Tayebati SK, and Zaccheo D (2002) The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 107:145-167.
3. Anderson PG, Boerth NJ, Liu M, McNamara DB, Cornwell TL, and Lincoln TM (2000) Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury. Arterioscler Thromb Vasc Biol 20:2192-2197.
4. 1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2. Am J Physiol Renal Physiol 293:F306-F315.
5. Ca channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase. Am J Physiol Lung Cell Mol Physiol 284:L1004- L1011.
6. Brenner R, Peréz GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, and Aldrich RW (2000) Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407:870-876.
7. 3 on BK channels of porcine coronary artery smooth muscle cells]. Sheng Li Xue Bao 57:303-309.
8. 2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol 29:412-418.
9. Felder CC, Blecher M, and Jose PA (1989) Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. J Biol Chem 264:8739-8745.
10. 1A dopamine receptors: evidence from D1A knockout mice. Mol Pharmacol 51:6-11.
11. 5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 51:360-366.
12. + currents in human coronary artery vascular smooth muscle cells. Circ Res 78:676-688.
13. Ca channels by cyclic AMP-induced stimulation of the cyclic GMP-dependent protein kinase. J Cardiovasc Pharmacol 34:619-627.
14. q/11 proteins in spontaneously hypertensive rats. Am J Physiol 272:F339-F346.
15. Hussain T and Lokhandwala MF (2003) Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228:134-142.
16. 5 receptors. J Neurochem 95:1387-1400.
17. Jackson WF (2000) Ion channels and vascular tone. Hypertension 35:173-178.
18. Jose PA, Eisner GM, and Felder RA (2003) Regulation of blood pressure by dopamine receptors. Nephron Physiol 95:19-27.
19. Kawano H, Kawano T, Tanaka K, Eguchi S, Takahashi A, Nakaya Y, and Oshita S (2008) Effects of dopamine on ATP-sensitive potassium channels in porcine coronary artery smooth-muscle cells. J Cardiovasc Pharmacol 51:196-201.
20. Missale CX, Nash SR, Robinson SW, Jaber M, and Caron MG (1998) Dopamine receptors: from structure to function. Pharm Rev 78:189-225.
21. + channels. Circulation 103:1992-1998.
22. Nelson MT and Quayle JM (1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268:C799-C822.
23. 1 receptor protein in the human heart and kidney. Hypertension 30:725-729.
24. Robertson BE, Schubert R, Hescheler J, and Nelson MT (1993) cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 265:C299-C303.
25. 5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 75:447-453.
26. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, and Felder RA (1999) Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33:1036-1042.
27. Ca channel in smooth muscle. Trends Pharmacol Sci 22:505-512.
28. Sibley DR and Monsma FJ Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61-69.
29. Vaithianathan T, Bukiya A, Liu J, Liu P, Asuncion-Chin M, Fan Z, and Dopico A (2008) Direct regulation of BK channels by phosphatidylinositol 4,5-bisphosphate as a novel signaling pathway. J Gen Physiol 132:13-28.
30. Wargo AA, Slotkoff LM, Jose PA, Pelayo JC, and Eisner GM (1982) Cyclic nucleotide response to stimulation in isolated glomeruli from dog kidney. Nephron 32:165-169.
31. 1 dopamine receptor agonists. Synapse 21:177-187.
32. 5 subtype of the dopamine receptor. Neuroendocrinology 69:209-216.
33. Ca channels through a cGMP-dependent mechanism. Circ Res 77:936-942.
34. + channels in human coronary artery smooth muscle cells. Cardiovasc Res 53:650-661.
35. Ca channel activity in coronary artery smooth muscle cells. Circ Res 86:897-905.
36. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Horio T, and Takeda T (1993) Interaction between a phorbol ester and dopamine DA1 receptors on vascular smooth muscle. Am J Physiol 264:F24-F30.
37. 1A receptor regulation of phospholipase C isoform. J Biol Chem 271:19503-19508.
38. 1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 66:2167-2180.
39. 5 dopamine receptors in the nephron. Hypertension 41:604-610.
40. 2 action in human coronary artery smooth muscle: role of potassium channels and signaling cross-talk. J Vasc Res 39:477-488.